Oxford London Lecture 2016: Vaccines for Ebola: Tackling a Market Failure
Oxford London Lecture 2016: Vaccines for Ebola: Tackling a Market Failure
Δημοσιεύτηκε στις 11 Μαρ 2016
In
2014 the largest ever outbreak of Ebola virus disease took the world by
surprise. This infectious disease has one of the highest case fatality
rates known to medicine and most of those who become ill die. Over
11,000 people died in West Africa before the outbreak was finally
brought under control. The disease dealt a devastating blow to three of
the world’s poorest countries and cost an estimated $5bn globally. No
drugs or vaccines were licensed or available in mid-2014.
There
are several lessons to be learned. Many potential solutions have been
proposed to provide vaccine stockpiles or to undertake large scale
prevention vaccination against future outbreaks. Professor Adrian Hill
discusses the pros and cons of these and the likelihood of any receiving
the financing that could allow them to happen.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου